dronabinol has been researched along with Leukemia, Promyelocytic, Acute in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Akmut, F; Blumenstock, G; Bonin, M; Bonzheim, I; Bühring, HJ; Dreher, ST; Ganief, T; Haeusser, L; Haverkamp, T; Illing, B; Kampa-Schittenhelm, KM; Mau-Holzmann, UA; Schittenhelm, MM; Schleicher, E; Tsintari, V; Vogel, W | 1 |
1 other study(ies) available for dronabinol and Leukemia, Promyelocytic, Acute
| Article | Year |
|---|---|
Epigenetic activation of O-linked β-N-acetylglucosamine transferase overrides the differentiation blockage in acute leukemia.
Topics: Apoptosis; Cells, Cultured; DNA Methylation; Dronabinol; Drug Repositioning; Epigenesis, Genetic; Hematopoiesis; Humans; Isocitrate Dehydrogenase; Jurkat Cells; Leukemia, Promyelocytic, Acute; Male; N-Acetylglucosaminyltransferases; Psychotropic Drugs; Transcription Initiation Site; Young Adult | 2020 |